Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte Extraction. (June 2017)

• Record Type: Journal Article
• Authors: Tokar, Jacob J.; Warrick, Jay W.; Guckenberger, David J.; Sperger, Jamie M.; Lang, Joshua M.; Ferguson, J. Scott; Beebe, David J.
• Other Names: Ho Dean guest-editor.; Zarrinpar Ali guest-editor.
• Is Part Of: SLAS technology. Volume 22:Number 3(2017)
• Page Start: 348
• Page End: 357
• Publication Date: 2017-06
• Subjects: lab on a chip -- microtechnology -- lung cancer -- bronchoalveolar -- lavage -- solid-phase extraction -- clinical automation; Medical laboratory technology -- Periodicals; Laboratories -- Equipment and supplies -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.075
• DOI: 10.1177/2472630317696780
• Languages: English
• ISSNs: 2472-6303

Abstract

Although average survival rates for lung cancer have improved, earlier and better diagnosis remains a priority. One promising approach to assisting earlier and safer diagnosis of lung lesions is bronchoalveolar lavage (BAL), which provides a sample of lung tissue as well as proteins and immune cells from the vicinity of the lesion, yet diagnostic sensitivity remains a challenge. Reproducible isolation of lung epithelia and multianalyte extraction have the potential to improve diagnostic sensitivity and provide new information for developing personalized therapeutic approaches. We present the use of a recently developed exclusion-based, solid-phase-extraction technique called SLIDE (Sliding Lid for Immobilized Droplet Extraction) to facilitate analysis of BAL samples. We developed a SLIDE protocol for lung epithelial cell extraction and biomarker staining of patient BALs, testing both EpCAM and Trop2 as capture antigens. We characterized captured cells using TTF1 and p40 as immunostaining biomarkers of adenocarcinoma and squamous cell carcinoma, respectively. We achieved up to 90% (EpCAM) and 84% (Trop2) extraction efficiency of representative tumor cell lines. We then used the platform to process two patient BAL samples in parallel within the same sample plate to demonstrate feasibility and observed that Trop2-based extraction potentially extracts more target cells than EpCAM-based extraction.